Alendronate Sodium
Active substance: alendronate
TABLET · ALENDRONATE SODIUM 35 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals of New York LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ALENDRONATE SODIUM · 35 mg/1
Registration
- Registration number
- 0115-1679
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0115-1679 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0115-1679 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0115-1679 · Verified 2026-10-09 · open in source